Private Placement
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Control Bionics Ltd. has announced a successful private placement to raise funds for growth initiatives, as detailed in their filing. The funds will support revenue growth and expansion into new markets, particularly with innovative products like NeuroNode Only and NeuroStrip. Control Bionics is positioned for future growth with a strengthened balance sheet and a growing pipeline of commercial opportunities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Control Bionics
- First Half FY25 Business Update
- Expansion into US Sports and Japanese Rehab Markets
- Coffee Microcaps Meeting Presentation
- Significant increase in revenue from faster NDIS approvals
- Addendum to notice of 2024 AGM
Later from Control Bionics
- FY25 Trading Update and NeuroStrip Progress
- Non-Renounceable Rights Issue
- Preliminary Final Report
- Rights Issue Offer Booklet
- Control Bionics Integrates with Apple BCI Protocol
Follow Control Bionics into a list and get an email when it puts out news.
Follow Control Bionics